ClinicalTrials.govpublic full text
A Clinical Study of Increased Dose of TA-650 in Patients With Psoriasis
plaque psoriasis, psoriatic arthritis, pustular psoriasis (excluding a localized), psoriatic erythroderma, infliximab, remicade, ta-650, psoriasis, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 834226
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.